NPS PHARMACEUTICALS INC: 10-Q filed 2011-11-03
What NPS PHARMACEUTICALS INC reported in its quarterly report filed 2011-11-03 (fiscal Q3 2011): 32 published measures, 92 facts as tagged in accession 0001136261-11-000570.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2011-11-03
- Fiscal period
- fiscal Q3 2011
- Accession
- 0001136261-11-000570 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NPS PHARMACEUTICALS INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 237,443,000 | USD | |
| At 2010-12-31 | 228,905,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 276,002,000 | USD | |
| At 2010-12-31 | 384,180,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | -38,559,000 | USD | |
| At 2010-12-31 | -155,275,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 150,230,000 | USD | |
| At 2010-12-31 | 77,170,000 | USD | |
| At 2010-09-30 | 92,676,000 | USD | |
| At 2009-12-31 | 18,276,000 | USD |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | -29,920,000 | USD | 273 |
| 2010-01-01 to 2010-09-30 | -13,823,000 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 24,601,000 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 75,387,000 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 21,054,000 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 65,371,000 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 88,773,000 | USD | 273 |
| 2010-01-01 to 2010-09-30 | 93,352,000 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 14,199,000 | USD | 273 |
| 2010-01-01 to 2010-09-30 | -5,129,000 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | -981,814,000 | USD | |
| At 2010-12-31 | -954,183,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 86,749,000 | shares | 92 |
| 2011-01-01 to 2011-09-30 | 79,417,000 | shares | 273 |
| 2010-07-01 to 2010-09-30 | 60,400,000 | shares | 92 |
| 2010-01-01 to 2010-09-30 | 55,577,000 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 86,749,000 | shares | 92 |
| 2011-01-01 to 2011-09-30 | 79,417,000 | shares | 273 |
| 2010-07-01 to 2010-09-30 | 60,400,000 | shares | 92 |
| 2010-01-01 to 2010-09-30 | 55,577,000 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | -0.14 | USD/shares | 92 |
| 2011-01-01 to 2011-09-30 | -0.35 | USD/shares | 273 |
| 2010-07-01 to 2010-09-30 | -0.26 | USD/shares | 92 |
| 2010-01-01 to 2010-09-30 | -0.45 | USD/shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 0 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 18,000 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 1,082,000 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 1,082,000 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 3,044,000 | USD | |
| At 2010-12-31 | 1,142,000 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | -2,041,000 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 3,052,000 | USD | 273 |
| 2010-07-01 to 2010-09-30 | -3,727,000 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 6,787,000 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 224,121,000 | USD | |
| At 2010-12-31 | 215,895,000 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 10,589,000 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 31,150,000 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 10,741,000 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 35,287,000 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 40,616,000 | USD | |
| At 2010-12-31 | 82,145,000 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 9,429,000 | USD | |
| At 2010-12-31 | 9,429,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 26,642,000 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 72,335,000 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 24,781,000 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 58,584,000 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 20,227,000 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 52,267,000 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 19,365,000 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 44,672,000 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 86,070,817 | shares | |
| At 2010-12-31 | 66,986,940 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 943,205,000 | USD | |
| At 2010-12-31 | 798,840,000 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | -36,000 | USD | |
| At 2010-12-31 | 1,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 224,000 | USD | |
| At 2010-12-31 | 296,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 7,316,000 | USD | |
| At 2010-12-31 | 7,779,000 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | -12,349,000 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -27,631,000 | USD | 273 |
| 2010-07-01 to 2010-09-30 | -15,691,000 | USD | 92 |
| 2010-01-01 to 2010-09-30 | -25,044,000 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 6,413,000 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 17,028,000 | USD | 273 |
| 2010-07-01 to 2010-09-30 | 5,410,000 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 13,900,000 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 293,000 | USD | 273 |
| 2010-01-01 to 2010-09-30 | 85,000 | USD | 273 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 0 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 0 | USD | 273 |
| 2010-07-01 to 2010-09-30 | -2,000 | USD | 92 |
| 2010-01-01 to 2010-09-30 | 96,000 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | -10,308,000 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -30,665,000 | USD | 273 |
| 2010-07-01 to 2010-09-30 | -10,882,000 | USD | 92 |
| 2010-01-01 to 2010-09-30 | -30,749,000 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 17,717,000 | USD | 273 |
| 2010-01-01 to 2010-09-30 | -778,000 | USD | 273 |
Inspect the source
- Entity
- NPS PHARMACEUTICALS INC / CIK 0000890465
- Captured
- SEC response SHA-256
7d6d48126ad30927f73519842e4e7850d1723b99d58b6d67e7b74ebacdb98780
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000890465.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))